Company profilePharmaceutical#382 of 1,318 in Pakistan✓ No DRAP alerts

UNISON CHEMICAL WORKS

Pharmaceutical company · 44 brands · 47 molecules

Ranked #137 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

44 registered products 19 pharmaceutical brands 47 distinct molecules 0 DRAP alerts

Company overview

44
registered products
19
pharmaceutical brands
47
distinct molecules
9
therapeutic classes
0
DRAP alerts

UNISON CHEMICAL WORKS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 44 product registrations across 47 distinct molecules. Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Antianemic, Iron Preparations. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by UNISON

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Cardiac Care 1

Top molecules by brand count

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 3Antianemic, Iron Preparations · 2Antithrombotic Agents · 1Antimycotics Systemic Use · 1Other Anti-Baterials · 1Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 1Antiemetics & Antinauseants · 1Cardiac Care · 1Corticosteroids, Systemic Use · 1

Conditions treated

High Cholestrol · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official1 products · Rs 3,863.54 – Rs 3,863.54
Servaid1 products · Rs 236 – Rs 236
Median across source: Rs 3,863.54

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 132 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
SEARLE PAKISTAN (PVT.) LTD. holds 237 molecules not in this portfolio
AcetazolamideAdalimumabAlprazolamAmilorideAminophyllineAmitriptyline
Atco Pharma International (Pvt) Ltd holds 231 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAlbuterolAminophylline

Get the full profile for UNISON

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.